Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • M&A
  • News

AeroClean Technologies, Molekule To Combine In An All-Stock Merger Establishing An Industry-Leading Provider Of Premium, FDA-Cleared Air Purification Products And Solutions

By Michael Horton
October 3, 4:17 PM
Transaction Highlights   Creates a pro forma company with a substantial base of revenues, a solid balance sheet and a path to profitability. A broad range of highly complementary, proprietary and patented,

AERC

Read More
3 minute read
  • Management
  • News

Maravai LifeSciences Announces CEO Leadership Transition

By Michael Horton
October 3, 4:06 PM
Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that its Board of Directors has appointed William

MRVI

Read More
1 minute read
  • News

The Manitowoc Company Expands its Direct-to-Customer Footprint in Colorado, Wyoming, and Nebraska

By Michael Horton
October 3, 4:03 PM
The Manitowoc Company, Inc. (NYSE:MTW) ("the Company" or "Manitowoc"), a leading global manufacturer of cranes and lifting solutions, announced today that through its wholly-owned subsidiary, MGX

MTW

Read More
1 minute read
  • News
  • Offerings

Vertex Energy Files For Mixed-Securities Shelf Offering, Size Not Disclosed

By Michael Horton
September 30, 4:35 PM
-Reuters

VTNR

Read More
1 minute read
  • News

Adage Capital Partners Reports 5.04% Passive Stake In Adams Natural Resources Fund As Of Sept. 20, 2022

By Michael Horton
September 30, 4:34 PM
-Reuters

PEO

Read More
1 minute read
  • Earnings
  • News

Natuzzi Q2 EPS €(0.02), Sales €116.90M

By Michael Horton
September 30, 4:33 PM
Natuzzi (NYSE:NTZ) reported quarterly losses of €(0.02) per share. This is a 100 percent decrease over losses of €(0.01) per share from the same period last year. The company reported €116.90 million in sales this quarter.

NTZ

Read More
1 minute read
  • News
  • Offerings

Ligand Pharmaceuticals Files For Mixed-Securities Shelf Offering, Size Not Disclosed

By Michael Horton
September 30, 4:24 PM
-Reuters

LGND

Read More
2 minute read
  • News

Cantaloupe, Inc. Receives Nasdaq Notification Of Non-Compliance With Listing Rule 5250(c)(1)

By Michael Horton
September 30, 4:20 PM
Cantaloupe, Inc. (NASDAQ:CTLP) ("Cantaloupe" or the "Company"), a digital payments and software services company that provides end-to-end technology solutions for the unattended retail market,

CTLP

Read More
1 minute read
  • News
  • Offerings

Immunocore Says Selling Stockholders Offering 79M Shares Of Common Stock

By Michael Horton
September 30, 4:19 PM
-Reuters

IMCR

Read More
1 minute read
  • News

Clene To Report HEALEY ALS Platform Trial Topline Results On Monday, October 3

By Michael Horton
September 30, 4:13 PM
Clene Inc. (NASDAQ:CLNN) along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of

CLNN

Posts pagination

Previous 1 … 143 144 145 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service